Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

NCT03425526 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Immunocompromised

Interventions

BIOLOGICAL: Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes

Sponsor

M.D. Anderson Cancer Center

Collaborators

National Cancer Institute (NCI)